Psychiatry

P300-mediated modulations in self-other processing under psychedelic psilocybin are related to connectedness and changed meaning: A window into the self-other overlap

Smigielski, L., Kometer, M., Scheidegger, M., Stress, C., Preller, K. H., Koenig, T., & Vollenweider, F. X. | Human brain mapping | 21 Aug 2020

The Current Status of Psychedelics in Psychiatry

Nutt, D., & Carhart-Harris, R. | JAMA psychiatry | 29 July 2020

Changes in inflammatory biomarkers are related to the antidepressant effects of Ayahuasca

Galvão-Coelho, N. L., de Menezes Galvão, A. C., de Almeida, R. N., Palhano-Fontes, F., Campos Braga, I., Lobão Soares, B., de Araujo, D. B. | Journal of Psychopharmacology | 10 Jul 2020

Historic psychedelic drug trials and the treatment of anxiety disorders

Weston, N. M., Gibbs, D., Bird, C. I., Daniel, A., Jelen, L. A., Knight, G., & Rucker, J. J. | Depression and Anxiety | 05 July 2020

3,4-methylenedioxymethamphetamine (MDMA)-assisted psychotherapy for victims of sexual abuse with severe post-traumatic stress disorder: an open label pilot study in Brazil

Jardim, A. V., Jardim, D. V., Chaves, B. R., Steglich, M., Ot’alora G, M., Mithoefer, M. C., Doblin, R. | Brazilian Journal of Psychiatry | 3 July 2020

A randomized, double-blind, active placebo-controlled study of efficacy, safety, and durability of repeated vs single subanesthetic ketamine for treatment-resistant depression

Shiroma, P. R., Thuras, P., Wels, J., Albott, C. S., Erbes, C., Tye, S., & Lim, K. O. | Translational psychiatry | 26 June 2020

Spotlight commentary: REBUS and the anarchic brain

Carhart-Harris, R. L., & Friston, K. J. | Pharmacological reviews | 12 June 2020

A Meta-Analysis of Placebo-Controlled Trials of Psychedelic-Assisted Therapy

Luoma, J. B., Chwyl, C., Bathje, G. J., Davis, A. K., & Lancelotta, R. | Journal Of Psychoactive Drugs | 12 June 2020

Mystical Experiences in Retrospective Reports of First Times Using a Psychedelic in Finland

Kangaslampi, S., Hausen, A., & Rauteenmaa, T. | Journal of Psychoactive Drugs | 8 June 2020

Broadening Your Mind to Include Others: The relationship between serotonergic psychedelic experiences and maladaptive narcissism

van Mulukom, V., Patterson, R., & van Elk, M. | Psychopharmacology (Berl) | 29 May 2020

Me, myself, bye: regional alterations in glutamate and the experience of ego dissolution with psilocybin

Mason, N. L., Kuypers, K. P. C., Müller, F., Reckweg, J., Tse, D. H. Y., Toennes, S. W., ... & Ramaekers, J. G. | Neuropsychopharmacology | 23 May 2020

Esketamine Nasal Spray for Rapid Reduction of Major Depressive Disorder Symptoms in Patients Who Have Active Suicidal Ideation With Intent: Double-Blind, Randomized Study (ASPIRE I)

Fu, D. J., Ionescu, D. F., Li, X., Lane, R., Lim, P., Sanacora, G., ... & Canuso, C. M. | 12 May 2020 | The Journal of clinical psychiatry

MDMA-assisted psychotherapy for people diagnosed with treatment-resistant PTSD: what it is and what it isn’t

Morgan, L. | Annals of General Psychiatry | 12 May 2020

Psilocybin: from ancient magic to modern medicine

Nichols, D. E. | The Journal of Antibiotics | 12 May 2020

Long-term Follow-Up Outcomes of MDMA-assisted Psychotherapy for Treatment of PTSD: A Longitudinal Pooled Analysis of Six Phase 2 Trials

Jerome, L., Feduccia, A. A., Wang, J. B., Hamilton, S., Yazar-Klosinski, B., Emerson, A., ... & Doblin, R. | Psychopharmacology | 11 May 2020

Psychedelic treatment of functional neurological disorder: a systematic review

Butler, M., Seynaeve, M., Nicholson, T. R., Pick, S., Kanaan, R. A., Lees, A., ... & Rucker, J. | Therapeutic Advances in Psychopharmacology | 11 May 2020

Can Psychedelics Alleviate Symptoms of Cluster Headache and Accompanying Mental Health Problems? A Case Report Involving Hawaiian Baby Woodrose

Johnson, S., & Black, Q. C. | Journal of Psychoactive Drugs | 7 May 2020

Psilocybin and LSD Have No Long-Lasting Effects in an Animal Model of Alcohol Relapse

Meinhardt, M. W., Güngör, C., Skorodumov, I., Mertens, L. J., & Spanagel, R. | Neuropsychopharmacology | 5 May 2020

Chronic pain and psychedelics: a review and proposed mechanism of action

Castellanos, J. P., Woolley, C., Bruno, K. A., Zeidan, F., Halberstadt, A., & Furnish, T. | Regional Anesthesia & Pain Medicine | 4 May 2020

The Viability of Microdosing Psychedelics as a Strategy to Enhance Cognition and Well-being – An Early Review

Bornemann, J. | Journal of Psychoactive Drugs | 2 May 2020

Psychedelics and Psychedelic-Assisted Psychotherapy

Reiff, C. M., Richman, E. E., Nemeroff, C. B., Carpenter, L. L., Widge, A. S., Rodriguez, C. I. | American Journal of Psychiatry | 1 May 2020

A Single Administration of the Atypical Psychedelic Ibogaine or Its Metabolite Noribogaine Induces an Antidepressant-Like Effect in Rats

Rodríguez, P., Urbanavicius, J., Prieto, J. P., Fabius, S., Reyes, A. L., Havel, V., ... & Carrera, I. | ACS Chemical Neuroscience | 24 April 2020